Newly Approved Laser Systems for Onychomycosis

Aditya K. Gupta Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Canada.
Mediprobe Research Inc, London, Ontario, Canada.

Search for other papers by Aditya K. Gupta in
Current site
Google Scholar
PubMed
Close
 MD, PhD, FRCP (C), FAAD
and
Fiona Simpson Mediprobe Research Inc, London, Ontario, Canada.

Search for other papers by Fiona Simpson in
Current site
Google Scholar
PubMed
Close
 HBSc

Laser systems are a new treatment area for onychomycosis. As of January 2012, the US Food and Drug Administration (FDA) has approved four laser systems for the “temporary increase of clear nail in onychomycosis.” The FDA has approved these devices on the basis of “substantial equivalence” to predicate devices with similar technical specifications and applications. Laser therapy appears to be a promising alternative to traditional pharmacotherapy, but these systems have been tested in only limited clinical trials; therefore, it is not possible to compare their efficacy to the oral and topical drugs currently used in the treatment of onychomycosis. (J Am Podiatr Med Assoc 102 (5): 428-430, 2012)

Corresponding author: Aditya K. Gupta, MD, PhD, FRCP (C), FAAD, 645 Windermere Road, London, Ontario, Canada N5X 2P1. (E-mail: agupta@execulink.com)